2021

Mar
2021

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 05 Mar 2021 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 1,520,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Mar
2021

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 02 Mar 2021 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 8,539,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Feb
2021

SELENA+ ACCEPTED BY LEADING MEDICAL INSURANCE ORGANISATION IN SOUTH AFRICA

Feb 2021 – The output from SELENA+ Deep Learning System (DLS) was assessed and has been finally accepted by Discovery Health, the leading medical scheme administrator in South Africa for reimbursement under the Chronic Illness Benefit for Diabetes Mellitus. Under this scheme, beneficiaries who use SELENA+ for a diabetic retinopathy screening are entitled to reimbursement on receipt of a referral…

Read more

Feb
2021

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 24 Feb 2021 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 12,806,400 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Feb
2021

EYRIS WINS THE SINGAPORE SME 500 AWARD 2021

Feb 2021 – EyRIS is pleased to announce that we have been awarded the Singapore SME 500 Award 2021: ” Business Resilience amidst COVID-19 ” in recognition of Singapore’s Top 500 SMEs. The Singapore SME 500 Award 2021 recognises SMEs that have further displayed business resilience, maintaining business continuity and showcasing their ability to transform and sustain. Launched to recognise…

Read more

Feb
2021

TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RELATED PARTY TRANSACTIONS PROVISION OF FINANCIAL ASSISTANCE TO SUBSIDIARY COMPANY

NOVA MSC BERHAD 22 Feb 2021 Type Announcement Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) RELATED PARTY TRANSACTIONS Description PROVISION OF FINANCIAL ASSISTANCE TO SUBSIDIARY COMPANY   1.    Introduction Nova MSC Berhad (“NovaMSC” or “Company”) wishes to inform that its wholly-owned subsidiary, NovaHEALTH Pte Ltd (“NH”) has on 22 February 2021 entered into a Loan Agreement with EyRIS Pte…

Read more

Feb
2021

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 22 Feb 2021 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 100,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Jan
2021

EYRIS SIGNS MOU WITH DIABETES SINGAPORE

Jan 2021 – An estimated 19,000 people are diagnosed with diabetes locally each year, with over 90 per cent of people having Diabetes Type 2 Mellitus (D2M). Diabetic retinopathy (DR), a result of the damage of blood vessels in the retina, is the most common microvascular complication of diabetes and the leading cause of vision loss in working-age adults worldwide….

Read more

Jan
2021

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 26 Jan 2021 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 120,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Jan
2021

HSC MEDICAL CENTRE TO IMPLEMENT VESALIUS AS PART OF ITS EXPANSION PLAN

Jan 2021 – HSC Medical Center (HSC), conveniently located in the heart of Kuala Lumpur, within walking distance of the iconic Petronas Twin Towers was officially opened by the Minister of Health on 18 February 2003. It is an award-winning medical centre and a one-stop advanced health screening hub for local and international visitors and patients. Apart from offering comprehensive health…

Read more

Jan
2021

SELENA+ RECEIVES REGULATORY APPROVAL IN INDONESIA

Jan 2021 – In Indonesia, it is estimated that nearly 16 million adults to be living with type 2 diabetes. More worringly, experts estimate more than half of diabetes cases in Indonesia remain undiagnosed, especially among young people. Every is at risk of going blind. Around a third of diabetics develop some form of eye health complication and is at…

Read more

Jan
2021

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 11 Jan 2021 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 7,210,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more